Background illustration for clinical trials search

Paid Clinical Trials Buffalo

Discover 779 paid clinical trials in Buffalo, New York. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2
Active & Responsive

Cardiovascular Risk Reduction for Adults With Food Insecurity Using Structured Incentives

for
Cardiovascular Diseases
Location: Buffalo NY
Sponsor: State University of New York at Buffalo

Sex: All

Age: 18+

Code: NCT06818669

Recruiting
Active & Responsive

A Randomized Phase 1/2 Trial of Low Dose Anti-thymocyte Globulin (ATG) With Subsequent Adalimumab or Verapamil in New Onset Type 1 Diabetes

for
Type 1 Diabetes, New Onset
Location: Buffalo NY, Pittsburgh PA, New Haven CT,
Sponsor: City of Hope Medical Center

Sex: All

Age: 9 - 20

Code: NCT07061574

Phase 1, Phase 2, Recruiting
Active & Responsive

A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)

for
Prostate Cancer, Prostatic Neoplasms
Location: Williamsville NY, Detroit MI, Ann Arbor MI,
Sponsor: Merck Sharp & Dohme LLC

Sex: Male

Age: 18+

Code: NCT06925737

Phase 3, Recruiting
Active & Responsive

Contour Neurovascular System™ ContiNued Access Investigational Device EXempTion (IDE) Trial (NEXT Trial)

for
Cerebral Aneurysms
Location: Buffalo NY, Philadelphia PA, Stony Brook NY,
Sponsor: Cerus Endovascular, Inc.

Sex: All

Age: 18 - 70+

Code: NCT06693011

Recruiting
Active & Responsive

AMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain

for
Obesity, Overweight, Osteoarthritis, Knee
Location: Niagara Falls, Troy MI, New York NY, Waterbury CT,
Sponsor: Novo Nordisk A/S

Sex: All

Age: 18+

Code: NCT07509307

Phase 3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Active & Responsive

Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity

for
Heart Failure With Preserved Ejection Fraction,
Location: Stoney Creek, Toronto, North York, Scarborough Village,
Sponsor: Amgen

Sex: All

Age: 18 - 70+

Code: NCT07037459

Phase 3, Recruiting
Active & Responsive

A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF

for
Heart Failure With Preserved Ejection Fraction (HFpEF),
Location: Stoney Creek, Oakville, North York, Newmarket, Kingston,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT07761117

Phase 3, Recruiting
Active & Responsive

A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity

for
Obesity, Overweight and/or Obesity, Overweight
Location: Hamilton, Toronto, Flint MI, Baltimore MD, New York NY,
Sponsor: Pfizer

Sex: All

Age: 18+

Code: NCT07595549

Phase 3, Recruiting
Active & Responsive

A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes

for
Obesity, Overweight
Location: Stoney Creek, Hamilton, Brampton, Rochester NY,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT07321886

Phase 3, Recruiting
Active & Responsive

A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain

for
Obesity, Knee Osteoarthritis (OA)
Location: Westfield NY, Guelph, Waterbury CT, Hamden CT,
Sponsor: Novo Nordisk A/S

Sex: All

Age: 18+

Code: NCT07481630

Phase 3, Recruiting
Active & Responsive

A Study of Zasocitinib in Adults With Nonsegmental Vitiligo

for
Nonsegmental Vitiligo
Location: Hamilton, Oakville, Toronto, Peterborough, Barrie,
Sponsor: Takeda

Sex: All

Age: 18 - 70+

Code: NCT07108283

Phase 2, Recruiting
Active & Responsive

A Study To Learn About Two Study Medicines (PF-07275315 And PF-07264660) In People Who Have Moderate To Severe Atopic Dermatitis

for
Atopic Dermatitis
Location: Hamilton, Toronto, Mississauga, East Syracuse NY,
Sponsor: Pfizer

Sex: All

Age: 18+

Code: NCT05995964

Phase 2, Recruiting
Active & Responsive

A Clinical Trial of Adjuvant Intismeran (V940) With or Without Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) in High-Risk Stage I Non-Small Cell Lung Cancer (V940-014)

for
Non-small Cell Lung Cancer
Location: Hamilton, Kingston, Morgantown WV, Ottawa, Albany NY,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT07513376

Phase 3, Recruiting
Active & Responsive

A Study of LY4257496 in Participants With Cancer (OMNIRAY)

for
Breast Neoplasms, Colorectal Neoplasms, Prostate Neoplasm,
Location: Hamilton, Toronto, Detroit MI, New York NY,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT07114601

Phase 1, Recruiting
Active & Responsive

A Study of Brenipatide in Adult Participants With Major Depressive Disorder

for
Depressive Disorder, Major
Location: Hamilton, Sarnia, Troy MI, Ottawa, West Chester PA,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18 - 70+

Code: NCT07412756

Phase 3, Recruiting
Active & Responsive

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)

for
Obesity, Overweight
Location: Hamilton, Rochester NY, Binghamton NY, Newport PA,
Sponsor: Amgen

Sex: All

Age: 18 - 70+

Code: NCT07684235

Phase 3, Recruiting
Active & Responsive

A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity

for
Obesity, Heart Failure
Location: Hamilton, North York, Toronto, Waterloo, Southfield MI,
Sponsor: Novo Nordisk A/S

Sex: All

Age: 18+

Code: NCT07567001

Phase 3, Recruiting
Active & Responsive

A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females

for
Irritable Bowel Syndrome
Location: Hamilton, Toronto, London, Cleveland OH, Sarnia,
Sponsor: Dynogen Pharmaceuticals

Sex: Female

Age: 18 - 65

Code: NCT00547469

Phase 2, Phase 3, Recruiting
Active & Responsive

LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:

for
Ulcerative Colitis
Location: Hamilton, Mississauga, Utica NY, Clinton Township MI,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18 - 70+

Code: NCT07186101

Phase 2, Recruiting
Active & Responsive

A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)

for
Crohn's Disease
Location: Oakville, Mississauga, Toronto, Barrie, London,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 16 - 70+

Code: NCT06430801

Phase 3, Recruiting